Mon, November 8, 2021

Salveen Richter Downgraded (BLUE) to Strong Sell and Decreased Target to $10 on, Nov 8th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-10-on-nov-8th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Salveen Richter of Goldman Sachs, Downgraded "bluebird bio, Inc." (BLUE) to Strong Sell and Decreased Target from $23 to $10 on, Nov 8th, 2021.

Salveen has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 2 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • John Newman of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $20 on, Tuesday, August 10th, 2021
  • Yanan Zhu of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $25 on, Tuesday, August 10th, 2021


This is the rating of the analyst that currently disagrees with Salveen


  • Difei Yang of "Mizuho" Maintained at Strong Buy with Decreased Target to $23 on, Wednesday, September 22nd, 2021